Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Cardiac involvement in lymphomas. Review of literature and case report of the clinical course of B-large-cell lymphoma

https://doi.org/10.20996/1819-6446-2015-11-6-610-617

Full Text:

Abstract

Clinical case of successful chemotherapy of patient with cardiac involvement in lymphoma, one of manifestations of which was the heart rhythm and conduction disorder, is presented as illustration. The data on the epidemiology of cardiac involvement in hematologic diseases, particularly in lymphomas and their clinical manifestations, modern diagnostic and treatment are presented. Clinical case of successful chemotherapy of patient with cardiac involvement in lymphoma, one of manifestations of which was the heart rhythm and conduction disorder, is presented as illustration.

About the Authors

I. Yu. Gadaev
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


V. I. Ershov
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


O. V. Bochkarnikova
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


I. Ya. Sokolova
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


D. A. Budanova
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


E. S. Kotova
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


A. S. Lishuta
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8-2, Moscow, 119991 Russia
Russian Federation


References

1. Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors-diagnosis and surgical treatment. Dtsch Arztebl Int 2014;111(12):205-11.

2. O’Mahony D, Piekarz RL, Bandettini WP, et al. Cardiac involvement with lymphoma: A review of the literature. Clin Lymphoma Myeloma 2008; 8(4): 249-52.

3. Alvarez J, Vivancos R, de Mora M, et al. Primary cardiac lymphoma: presentation of a case and review of the literature. Rev Esp Cardiol 1997; 50: 444-7.

4. Doronin V.A., Morozova N.V., Gradoboev M.I., et al. Primary cardiac diffuse large cell B-cell lymphoma: Case report and review of literature. Klinicheskaya Onkogematologiya 2009; 2(4): 358-61. In Russian (Доронин В.А., Морозова Н.В., Градобоев М.И., и др. Первичная диффузная в-крупноклеточная лимфома сердца. Клиническое наблюдение и обзор литературы. Клиническая Онкогематология 2009; 2(4): 358-61).

5. Rahbar K., Seifarth H., Schäfers M, et al. Differentitation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med 2012;53:856-63.

6. Bertheart J. Carney complex (CNC). Orphanet J Rare Dis 2006;1:21.

7. Mariscalco G., Bruno VD., Borsani P., et al. Papillary fibroelastoma: insight to a primary cardiac valve tumor: L Card Surg 2010; 25: 198-205.

8. Patel J., Melly L., Sheppard M.N. Primary cardiac lymphoma: B-and T-cell cases at a specialist UK centre. Ann Oncol 2010;21(5):1041-5.

9. Petrich A., Cho SI, Billett H. Primary Cardiac Lymphoma. An Analysis of Presentation, Treatment, and Outcome Patterns. Cancer 2011;117:581-9.

10. Ikeda H, Nakamura S, Nishimaki H, et al. Primary lymphoma of the heart: case report and literature review. Pathol Int 2004; 54: 187-95.

11. Anghel G, Zoli V, Petti N, et al. Primary cardiac lymphoma: report of 2 cases occurring in immunocompetent subjects. Leuk Lymphoma 2004: 45; 781-8.

12. Ceresoli GL, Ferreri AJ, Bucci E, et al. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer 1997: 80; 1497-506.

13. Sato H, Takahashi M. Non-Hodgkin's malignant lymphoma of the bone with intracavitary cardiac involvement. Intern Med 1993;32(6):502-7.

14. Cho SW, Kang YJ, Kim TH, et al. Primary cardiac lymphoma presenting with atrioventricular block. Korean Circ J 2010; 40:94-8.

15. Kaderli AA, Baran I, Aydin O, et al. Diffuse involvement of the heart and great vessels in primary cardiac lymphoma. Eur J Echocardiogr 2010;11(1):74-6.

16. Danbauch SS, Okpapi JU, Maisaka MM, Ibrahim A. Ventricular tachycardiain a patient with lymphocytic (non Hodgkin’s) lymphoma. Cent Afr J Med 1995;41:169-71.

17. Miyashita T, Miyazawa I, Kawaguchi T, et al. A case of primary cardiac B cell lymphoma associated with ventricular tachycardia, successfully treated with systemic chemotherapy and radiotherapy: a longterm survival case. Jpn Circ J 2000;64:135-8.

18. Tanaka Y, Yamabe H, Yamasaki H, et al. A case of reversible ventricular tachycardia and complete atrioventricular block associated with primary cardiac B-cell lymphoma. Pacing Clin Electrophysiol 2009; 32: 816-9.

19. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF. Lymphosarcoma: review of 1269 cases. Medicine 1961; 40: 31.

20. Kober G, Magedanz A, Mohrs O, et al. Non-invasive diagnosis of a pedunculated left ventricular hemangioma: tumor classification and evaluation of relevant literature. Clin Res Cardiol 2007; 96: 227-31.

21. Schwab J, Haack G, Sinss D, et al. Diagnosis of left ventricular myxoma with cardiac magnetic resonance imaging. Clin Res Cardiol 2007; 96:189-90.

22. Majano-Lainez RA. Cardiac tumors: a current clinical and pathological perspective. Crit Rev Oncog 1997;8:293-303.

23. Meng Q, Lai H, Lima J, et al. Echocardiographic and pathologic characteristics of primary cardiac tumors: a study of 149 cases. Int J Cardiol 2002;84:69-75.

24. Faganello G, Belham M, Thaman R, et al. A case of primary cardiac lymphoma: analysis of the role of echocardiography in early diagnosis. Echocardiography 2007; 24:889-92.

25. Hoffmann U, Globits S, Schima W, et al. Usefulness of magnetic resonance imaging of cardiac and paracardiac masses. Am J Cardiol 2003;92:890-5.

26. Wang ZJ, Reddy GP, Gotway MB, et al. CT and MR imaging of pericardial disease. Radiographics 2003; 23:S167-80.

27. Nguyen JD, Carrasquillo JA, Little RF, et al. Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases. Clin Nucl Med 2003;28:979-80.

28. Romer W, Garbrecht M, Fuchs C, et al. Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart. Circulation 1998;97:2577-8.

29. Israel O, Keidar Z., Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med 2004; 3: 166-79.

30. Collins C.D. PET in lymphoma. Cancer Imaging 2006; 6: S63-70.

31. Seam P., Juweid M.E., Cheson B.D. The role of FDG-PET scans in patients with lymphoma. Blood 2007;110:3507-16.

32. Abramowitz Y, Hiller N, Perlman G, et al. The diagnosis of primary cardiac lymphoma by right heart catheterization and biopsy using fluoroscopic and transthoracic echocardiographic guidance. Int J Cardiol 2007;118:e39-40.

33. Chim CS, Chan AC, Kwong YL, et al. Primary cardiac lymphoma. Am J Hematol 1997;54:79-83.

34. Kang SM, Rim SJ, Chang HJ, et al. Primary cardiac lymphoma diagnosed by transvenous biopsy under transesophageal echocardiographic guidance and treated with systemic chemotherapy. Echocardiography 2003;20:101-3.

35. Jurkovich D, de Marchena E, Bilsker M, et al. Primary cardiac lymphoma diagnosed by percutaneous intracardiac biopsy with combined fluoroscopic and transesophageal echocardiographic imaging. Catheter Cardiovasc Interv 2000;50:226-33.

36. Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004;109(25):3122-31.

37. Curigliano G, Cardinale D, Suter T, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23 Suppl 7:vii155-66.

38. Sayed-Ahmed MM, Shouman SA, Rezk BM, Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria. Pharmacol Res 2000;41(2):143-50.

39. Silber JH, Cnaan A, Clark BJ, Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 2004;22(5):820-8.

40. Ganz WI1, Sridhar KS, Ganz SS, Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 1996;53(6):461-70.

41. Nakamae H, Tsumura K, Terada Y, Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone. Cancer 2005;104(11):2492-8.

42. Bosch X, Esteve J, Sitges M, et al. Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial. J Card Fail 2011;17(8): 643-8.

43. Kalay N, Basar E, Ozdogru I, Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 2006;48(11):2258-62.


For citation:


Gadaev I.Y., Ershov V.I., Bochkarnikova O.V., Sokolova I.Y., Budanova D.A., Kotova E.S., Lishuta A.S. Cardiac involvement in lymphomas. Review of literature and case report of the clinical course of B-large-cell lymphoma. Rational Pharmacotherapy in Cardiology. 2015;11(6):610-617. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-6-610-617

Views: 449


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)